Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pAd/WT1-IRES-nAmCyan Citations (3)

Originally described in: McCabe Lab Plasmids
Unpublished

Articles Citing pAd/WT1-IRES-nAmCyan

Articles
Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde. Wang N, Tan HY, Chan YT, Guo W, Li S, Feng Y. Oncotarget. 2017 Nov 11;8(62):105848-105859. doi: 10.18632/oncotarget.22406. eCollection 2017 Dec 1. PubMed
Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs beta-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma. Tan HY, Wang N, Li S, Hong M, Guo W, Man K, Cheng CS, Chen Z, Feng Y. Cell Physiol Biochem. 2018;47(5):1819-1834. doi: 10.1159/000491063. Epub 2018 Jun 28. PubMed
Exploring hTERT promoter methylation in cutaneous T-cell lymphomas. Chebly A, Ropio J, Peloponese JM, Poglio S, Prochazkova-Carlotti M, Cherrier F, Ferrer J, Idrissi Y, Segal-Bendirdjian E, Chouery E, Farra C, Pham-Ledard A, Beylot-Barry M, Philippe Merlio J, Tomb R, Chevret E. Mol Oncol. 2021 Mar 14. doi: 10.1002/1878-0261.12946. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.